Abstract
N-acetylcysteine (NAC), the N-acetyl derivative of the amino acid cysteine, is perhaps best known for its wide use in the treatment of acetaminophen (paracetamol) toxicity, but it has been investigated for the treatment of myriad conditions. In this article we will review the uses of NAC in pulmonary diseases, the mechanism of action dosing, side effect profile and clinical implications in regard to COPD and idiopathic pulmonary fibrosis. One of the main targets of NAC is Inflammation and oxidative stress that are important factors in the pathogenesis of many chronic inflammatory lung disorders. While it is logical to conclude that the administration of antioxidants such as NAC will provide a mode of treatment for said conditions by targeting antioxidant-oxidant imbalance [8] and although the theory supporting the use of antioxidants is sound, it may not necessarily translate into clinical benefit. Based on the available evidence it is unlikely that mucolytics such as NAC will drastically affect symptoms, exacerbations or disease modification in COPD.
Keywords: Interstitial lung diseases, N-Acetylcysteine, pulmonary diseases, side effects.
Current Respiratory Medicine Reviews
Title:The Use of N-Acetylcysteine in Respiratory Diseases
Volume: 9 Issue: 5
Author(s): Shoshannah Levitt, Daniel Grupel, Maor Waldman, Tamir Tobias and Theodore K. Marras
Affiliation:
Keywords: Interstitial lung diseases, N-Acetylcysteine, pulmonary diseases, side effects.
Abstract: N-acetylcysteine (NAC), the N-acetyl derivative of the amino acid cysteine, is perhaps best known for its wide use in the treatment of acetaminophen (paracetamol) toxicity, but it has been investigated for the treatment of myriad conditions. In this article we will review the uses of NAC in pulmonary diseases, the mechanism of action dosing, side effect profile and clinical implications in regard to COPD and idiopathic pulmonary fibrosis. One of the main targets of NAC is Inflammation and oxidative stress that are important factors in the pathogenesis of many chronic inflammatory lung disorders. While it is logical to conclude that the administration of antioxidants such as NAC will provide a mode of treatment for said conditions by targeting antioxidant-oxidant imbalance [8] and although the theory supporting the use of antioxidants is sound, it may not necessarily translate into clinical benefit. Based on the available evidence it is unlikely that mucolytics such as NAC will drastically affect symptoms, exacerbations or disease modification in COPD.
Export Options
About this article
Cite this article as:
Levitt Shoshannah, Grupel Daniel, Waldman Maor, Tobias Tamir and Marras K. Theodore, The Use of N-Acetylcysteine in Respiratory Diseases, Current Respiratory Medicine Reviews 2013; 9 (5) . https://dx.doi.org/10.2174/1573398X10666140204230324
DOI https://dx.doi.org/10.2174/1573398X10666140204230324 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Pharmacogenomics in Aspirin Intolerance
Current Drug Metabolism The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Structure Function Analysis of Serpin Super-Family: "A Computational Approach"
Protein & Peptide Letters Hypersensitivity Reactions to Complementary and Alternative Medicine Products
Current Pharmaceutical Design Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Strategies for Leukotriene Modulation in Dermatology: Current Evidence and Visionary Perspectives
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Contact Allergy to Topical Corticosteroids: Update and Review on Cross- Sensitization
Recent Patents on Inflammation & Allergy Drug Discovery Efficacy and Safety of H1-Antihistamines: An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients
Current Medicinal Chemistry The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Inflammation & Allergy - Drug Targets (Discontinued) Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Cow’s Milk Allergy: Where have we Come from and where are we Going?
Endocrine, Metabolic & Immune Disorders - Drug Targets Isolated Perioperative Hypertension: Clinical Implications & Contemporary Treatment Strategies
Current Hypertension Reviews Genetic Predictors of Drug Hypersensitivity
Current Pharmaceutical Design Fixed Drug Eruption Due to Selective Hypersensitivity to Naproxen with Tolerance to other Propionic Acid NSAIDs
Recent Patents on Inflammation & Allergy Drug Discovery Review on Plants with Traditional Uses and Bio-activity against Hair Graying
Current Traditional Medicine Genes and Hypertension
Current Pharmaceutical Design An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions
Current Pharmaceutical Design Discovery of Highly Potent Small Molecule Kallikrein Inhibitors
Medicinal Chemistry